J. Moore

3.3k citations
25 papers · 2.4k · 1 hit paper · h-index 14

Impact in

Papers in

    • Cancer Immunotherapy and Biomarkers 4
    • HER2/EGFR in Cancer Research 3
    • CAR-T cell therapy research 3
    • Immunotherapy and Immune Responses 8

J. Moore

24 papers receiving 2.3k citations

J. Moore's Hit Papers

Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer. 1996 · 1.1k citations
1.1k0+10+20Years since publication2505007501000

Peers

J. Moore
Comparison fields: 5 of 99
  • Oncology 1.4k
  • Radiology, Nuclear Medicine and Imaging 917
  • Immunology 383
  • Hematology 161
  • Cancer Research 210
Replace J Klein with:
J Klein United States
Henry F. Sears United States
Vincent R. Zurawski United States
Agamemnon A. Epenetos United Kingdom
S. A. Eccles United Kingdom
Robert Stagg United States
Mark R. Albertini United States
Randall J. Brezski United States
Jean‐Pierre Mach Switzerland
Gundram Jung Germany
J. Moore relative to J Klein United States J Klein's profile →
Citations per field
00.5×1.5×2.2×
J Klein · 1×
Citations per year

Countries citing papers authored by J. Moore

Since Specialization
Citations

This map shows the geographic impact of J. Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Moore more than expected).

Fields of papers citing papers by J. Moore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Moore. The network helps show where J. Moore may publish in the future.

Co-authors

The 25 scholars most cited alongside J. Moore, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J. Moore Line = papers co-authored together J. Moore links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer.
Hit paper breakdown →
19961088
2 1985406
3
Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer.
1999229
4
Randomized multicenter trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANLL). Lederle Cooperative Group.
1990145
5 199693
6 199682
7 199966
8 199865
9 199555
10 200049
11
Low-dose cyclophosphamide and low-dose interleukin-2 for malignant melanoma.
198918
12 200017
13 199313
14 200013
15 199710
16 19929
17 19967
18 19944
19 20163
20 19972

About J. Moore

J. Moore is a scholar working on Oncology, Immunology, Pulmonary and Respiratory Medicine, Surgery and Radiology, Nuclear Medicine and Imaging, having authored 25 papers that have together received 2.4k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (8 papers), Cancer Immunotherapy and Biomarkers (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Virus-based gene therapy research (3 papers), HER2/EGFR in Cancer Research (3 papers), CAR-T cell therapy research (3 papers), Esophageal Cancer Research and Treatment (3 papers) and Gastric Cancer Management and Outcomes (3 papers). The work is most often cited by research in Oncology (1.4k citations), Radiology, Nuclear Medicine and Imaging (917 citations), Immunology (383 citations), Hematology (161 citations) and Cancer Research (210 citations). J. Moore has collaborated with scholars based in United Kingdom, Sweden and United States. Frequent co-authors include Helen R. Griffiths, José Baselga, Larry Norton, Andrew D. Seidman, Nancy T. Sklarin, Debu Tripathy, Christopher C. Benz, Paul Peter Rosen, I. Craig Henderson and Sharon A. Baughman. Their work appears in journals such as British Journal of Cancer, European Journal of Cancer, Annals of Oncology, British journal of surgery and Human Gene Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact